Skip to main content
. 2022 May 10;187(1):159–170. doi: 10.1530/EJE-22-0104

Table 3.

Hazard ratios estimating the relative risk of death from COVID-19 associated with baseline hormone concentration.§

Model Q1 (lowest) Q2 Q3 Q4 Q5 (highest) P-value (term)
Total testosterone (nmol/L)
 Events per quintile 112 94 86 68 78
n per quintile 31 992 32 169 32 081 31 933 31 789
 Model 1# 1.37 (1.07–1.75) 1.08 (0.85–1.41) 0.93 (0.78–1.14) 0.87 (0.79–0.98) ref. <0.001
 Model 2## 0.84 (0.65–1.12) 0.82 (0.63–1.10) 0.80 (0.66–1.00) 0.82 (0.75–0.93) ref. 0.008
SHBG (nmol/L)
 Events per quintile 76 79 87 86 110
n per quintile 31 980 32 121 32 054 31 982 31 827
 Model 1# 1.61 (1.23–2.07) 1.27 (0.98–1.64) 1.06 (0.86–1.30) 0.93 (0.85–1.02) ref. <0.001
 Model 2## 1.01 (0.77–1.34) 0.94 (0.72–1.24) 0.89 (0.71–1.11) 0.87 (0.79–0.97) ref. 0.008
cFT (pmol/L)
 Events per quintile 137 110 76 66 49
n per quintile 31 738 32 051 32 126 32 073 31 976
 Model 1# 1.13 (0.86–1.5) 0.93 (0.7–1.24) 0.89 (0.73–1.12) 0.91 (0.84–1.09) ref. 0.004
 Model 2## 0.86 (0.65–1.17) 0.81 (0.61–1.10) 0.83 (0.68–1.07) 0.89 (0.82–1.06) ref. 0.248

§Hazard ratios calculated for the medians of testosterone within each sample quintile (Q1–Q5), relative to the median for Q5. Quintile boundaries: testosterone: (nmol/L) Q1/2 9.0, Q2/3 10.8, Q3/4 12.5, and Q4/5 14.8 or (ng/dL) Q1/2 259, Q2/3 311, Q3/4 360, and Q4/5 427; SHBG: (nmol/L) Q1/2 25.8, Q2/3 33.1, Q3/4 40.5, and Q4/5 50.8; cFT: (pmol/L) Q1/2 171, Q2/3 201, Q3/4 230, and Q4/5 268. #Model 1 included terms for testosterone and age and region, with time modelled as a 3-level stratification factor plus an interaction of region with time (see Methods). ##Model 2 included model 1 terms + ethnicity (White vs not White), living with partner, educational attainment, alcohol consumption, smoking status, diet (red meat: high vs low vs none), physical activity, BMI, waist circumference, cholesterol, time blood sample collected, blood type, Townsend Index quintile, diabetes, hypertension, angina, atrial fibrillation, COPD, renal impairment, liver disease, thyroid disease, and use of lipid medications (a proxy for hyperlipidemia), glucocorticoids, opioids, and anticonvulsants, with the number of medications included as a proxy for overall comorbidity status. Continuous variables are modelled using restricted cubic splines (see Methods).